Skip to main content
OpenTrials

Clinical trial condition

Waldenström's Macroglobulinemia

Explore clinical trials studying Waldenström's Macroglobulinemia. Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Waldenström's Macroglobulinemia trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia

NCT07169331

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Sun Yat Sen University Cancer Center Guangzhou, Guangdong, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Affiliated Hospital of Hebei University Baoding, Hebei, China
View Trial Details
Completed

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)

NCT03053440

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 58 locations
View Trial Details
Completed

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

NCT02165397

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Emory University Hospital Atlanta, Georgia, United States
View all 48 locations
View Trial Details

Related conditions